Entering text into the input field will update the search result below

Medtronic initiates pivotal trial for PulseSelect System in atrial fibrillation

Mar. 04, 2021 3:28 PM ETMedtronic plc (MDT) StockMDTBy: Dulan Lokuwithana, SA News Editor
  • Medtronic plc (MDT -2.8%) has announced the first procedures in the investigational device exemption (“IDE”) pivotal trial to evaluate the PulseSelect Pulsed Field Ablation System in atrial fibrillation.
  • The first procedures were performed at Southcoast Health, the company said.
  • Conducted in

Recommended For You

More Trending News

About MDT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDT--
Medtronic plc